Biogen has announced plans to invest an additional $2bn in Research Triangle Park (RTP) in the US state of North Carolina.

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as ...

Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date ...

Biogen will invest an additional $2 billion in its existing manufacturing in North Carolina, the drugmaker said on Monday, as ...

The biotech giant will grow its footprint at Research Triangle Park, while Premix opens a life sciences manufacturing plant ...

(Reuters) -Drugmaker Biogen said on Monday it will invest an additional $2 billion in its existing manufacturing footprint in ...

Since starting operations in North Carolina 30 years ago, Biogen has spent approximately $10 billion to bolster its ...

Biogen will invest an extra $2 billion to expand its RTP facilities, focusing on AI-driven manufacturing and late-stage ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...

Biogen said it would invest an additional $2 billion in its existing facilities in North Carolina's Research Triangle Park. The biotechnology company on Monday said it has invested about $10 billion ...

One of North Carolina's largest biotechnology companies is expanding its operations with a $2 billion investment.